Chemoinformaics analysis of 4- (Diaminomethylideneamino) butanoic acid
| Molecular Weight | 561.517 | nRot | 9 |
| Heavy Atom Molecular Weight | 535.309 | nRig | 22 |
| Exact Molecular Weight | 561.184 | nRing | 3 |
| Solubility: LogS | -3.841 | nHRing | 1 |
| Solubility: LogP | 1.203 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 3 |
| Base Count | 3 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 18 |
| nHA | 6 | APOL | 72.7396 |
| nHD | 5 | BPOL | 35.1744 |
| QED | 0.248 |
| Synth | 2.898 |
| Natural Product Likeliness | -0.345 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.031 |
| HIA | 0.937 |
| CACO-2 | -6.557 |
| MDCK | 0.00000911 |
| BBB | 0.448 |
| PPB | 0.638922 |
| VDSS | 0.195 |
| FU | 0.445493 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.047 |
| CYP2c19-inh | 0.091 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.098 |
| CYP2c9-sub | 0.269 |
| CYP2d6-inh | 0.058 |
| CYP2d6-sub | 0.177 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.154 |
| CL | 3.084 |
| T12 | 0.325 |
| hERG | 0.141 |
| Ames | 0.01 |
| ROA | 0.062 |
| SkinSen | 0.069 |
| Carcinogencity | 0.028 |
| EI | 0.007 |
| Respiratory | 0.186 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.617353 |